18F-Fluorodeoxyglucose ( 18 F-FDG) positron emission tomography-computed tomography (PET/CT) is integral to the investigation and management of suspected or proven lung cancer (1) despite the nonspecific nature of the 18 F-FDG, which is a glucose analogue. An improved understanding in tumour biology and advances in therapeutic options has driven the need to better characterise tumours, and predict and monitor treatment response to new targeted cancer therapies. Some of the cancer-related cellular processes being investigated include tumour proliferation, amino acid metabolism, tumour hypoxia and angiogenesis. The majority of tracers being used to evaluate these processes remain restricted to preclinical and clinical research. There are also certain receptors which are expressed by specific cancers which can then be targeted by peptides, e.g. neuroendocrine tumours express somatostatin receptors which have an affinity to somatostatin analogues such as DOTA-peptides. 68 Ga-DOTA-peptides have an established role in PET imaging, including imaging of carcinoid tumours, but these are not specific to lung lesions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.